THERALY
Dead / Abandoned — Abandoned — no statement of use filed (as of 22 Dec 2025)
What this means for you
This application is over — abandoned 22 Dec 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97122963
- Mark type
- Stylized text
- Filed
- 12 Nov 2021
- Published for opposition
- 27 Sept 2022
- Abandoned
- 22 Dec 2025
- Attorney of record
- Todd S. Bontemps
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment of fibrotic diseases, chronic pancreatitis, systemic sclerosis, nonalcoholic steatohepatitis (NASH); pharmaceuticals for the treatment of oncology, diabetes, obesity, and ocular, metabolic, central nervous system and immune systems diseases and disorders
Owner
- Theraly Fibrosis, Inc., Gaithersburg, MD, US
- Theraly Fibrosis, Inc., Gaithersburg, MD, US
Prosecution history
- 22 Dec 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 22 Dec 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 02 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Oct 2025 — SOU EXTENSION 5 GRANTED
- 18 May 2025 — SOU EXTENSION 5 FILED
- 01 Oct 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 19 May 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Nov 2024 — SOU EXTENSION 4 GRANTED
- 21 Nov 2024 — SOU EXTENSION 4 FILED
- 21 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 21 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 May 2024 — SOU EXTENSION 3 GRANTED
- 20 May 2024 — SOU EXTENSION 3 FILED
- 20 May 2024 — SOU TEAS EXTENSION RECEIVED